A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance: Need a closer look!

肝细胞癌 乙型肝炎表面抗原 医学 内科学 胃肠病学 乙型肝炎 肝硬化 肿瘤科 乙型肝炎病毒 免疫学 病毒
作者
Weishun Lu
出处
期刊:Journal of Hepatology [Elsevier BV]
被引量:1
标识
DOI:10.1016/j.jhep.2023.09.016
摘要

A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearanceJournal of HepatologyVol. 77Issue 3PreviewAfter hepatitis B surface antigen (HBsAg) seroclearance, the risk of hepatocellular carcinoma (HCC) remains, and the optimal surveillance strategy has yet to be determined. Herein, we aimed to evaluate incidence and risk factors for HCC and establish a novel prediction model for HCC development after HBsAg seroclearance. Full-Text PDF The authors received no financial support to produce this manuscript. Wentian Lu (Conceptualization; Writing – original draft; Writing – review & editing). With great interest I read the article by Yang H et al.[1]Yang H. Bae S.H. Nam H. Lee H.L. Lee S.W. Yoo S.H. et al.A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance.J Hepatol. 2022; 77: 632-641Abstract Full Text Full Text PDF PubMed Scopus (16) Google Scholar The retrospective study predominantly developed a risk prediction model for hepatocellular carcinoma (HCC) after hepatitis B surface antigen (HBsAg) seroclearance. Of 831 patients finally included in the study, 40 developed HCC after HBsAg was cleared. By multivariate Cox proportional modeling, four independent risk factors, i.e., age at HBsAg seroclearance, presence of cirrhosis, family history of HCC, and more-than-moderate alcohol consumption, were included in the novel model. Notably, the model showed an excellent performance, with Harrell's C-index of 0.804 as well as the time-dependent AUROC curves for 5-year, 10-year, and 15-year prediction for HCC of 0.799, 0.835, and 0.817, respectively. However, I would like to raise the following comments: Firstly, the study aimed to investigate risk factors for HCC development after HBsAg seroclearance, and presence of cirrhosis at baseline was identified as one. However, some patients with diabetes, dyslipidemia, or heavy alcohol drinking were enrolled in this study. In other words, some cases of cirrhosis may mainly originate from the progression of nonalcoholic fatty liver disease (NAFLD) and/or alcoholic liver disease (ALD), which can also progress to HCC.[2]Polyzos S.A. Chrysavgis L. Vachliotis I.D. Chartampilas E. Cholongitas E. Nonalcoholic fatty liver disease and hepatocellular carcinoma:Insights in epidemiology, pathogenesis, imaging, prevention and therapy.Semin Cancer Biol. 2023; 93: 20-35Crossref Scopus (6) Google Scholar,[3]Gao B. Bataller R. Alcoholic liver disease: pathogenesis and new therapeutic targets.Gastroenterology. 2011; 141: 1572-1585Abstract Full Text Full Text PDF PubMed Scopus (1446) Google Scholar To some extent, the risk of HCC in patients with HBsAg seroclearance might be overestimated. Secondly, 16 cirrhotic patients were diagnosed by aspartate aminotransferase to platelet ratio (APRI) score or fibrosis-4 index (FIB-4) score, as described in Results Section. Both APRI and FIB-4 are calculated on the basis of some simple parameters, including platelet count.[4]Wai C.T. Greenson J.K. Fontana R.J. Kalbfleisch J.D. Marrero J.A. Conjeevaram H.S. et al.A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.Hepatology. 2003; 38: 518-526Crossref PubMed Scopus (3363) Google Scholar,[5]Sterling R.K. Lissen E. Clumeck N. Sola R. Correa M.C. Montaner J. et al.Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection.Hepatology. 2006; 43: 1317-1325Crossref PubMed Scopus (3039) Google Scholar According to univariate analysis, cirrhosis, low platelet count, and other parameters were associated with development of HCC, and they were included in multivariate analysis. That is to say, collinearity may occur in cirrhosis and platelet count. Thirdly, some patients diagnosed with hepatitis B virus infection may continue to receive antiviral treatment after HBsAg seroclearance.[6]Tang L.S.Y. Covert E. Wilson E. Kottilil S. Chronic Hepatitis B Infection: A Review.JAMA. 2018; 319: 1802-1813Crossref PubMed Scopus (447) Google Scholar And current evidence indicates that long-term nucleos(t)ide analogue therapy can significantly lower the chance of developing HCC in patients with chronic hepatitis B. Thus history of long-term antiviral therapy may be another factor associated with development of HCC.[7]Manne V. Gochanour E. Kowdley K.V. Current perspectives into the evaluation and management of hepatitis B: a review.Hepatobiliary Surg Nutr. 2019; 8: 361-369Crossref PubMed Google Scholar Despite the limitations of the study, additional analyses by including more meaningful parameters (e.g., history of long-term antiviral therapy after HBsAg seroclearance) in the future, even the further validation in large-scale prospective studies, will strengthen validity and credibility of the conclusions and improve this model. This novel predictive model, based on four easily accessible clinical variables, allows for reliable risk assessment of HCC, easy to implement and available to doctors from community hospitals to tertiary hospitals. In order to apply this model to clinical practice as soon as possible, it is proposed to develop a user-friendly software and/or website. The clinical promotion and wide application of the model will facilitate the improvement of scheme for HCC surveillance in patients with HBsAg seroclearance to optimize current guidelines. The authors declare no conflicts of interest that pertain to this work.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
甜蜜发带发布了新的文献求助10
2秒前
摩卡发布了新的文献求助10
3秒前
凡迪亚比应助Xw采纳,获得20
5秒前
gsj完成签到,获得积分10
8秒前
9秒前
10秒前
秋天完成签到,获得积分10
11秒前
淡定的惜关注了科研通微信公众号
14秒前
Zhy发布了新的文献求助10
14秒前
15秒前
蛋挞完成签到,获得积分10
17秒前
李健应助Junning采纳,获得10
19秒前
19秒前
tingting9发布了新的文献求助10
20秒前
21秒前
爆米花应助mark采纳,获得10
22秒前
22秒前
爱看文献的小恐龙完成签到,获得积分10
23秒前
小饼干完成签到 ,获得积分10
25秒前
萧瑟处完成签到 ,获得积分10
26秒前
26秒前
27秒前
孙燕应助鹤鸣采纳,获得30
28秒前
29秒前
loski发布了新的文献求助10
31秒前
随便不放假完成签到 ,获得积分10
32秒前
淡定的惜发布了新的文献求助10
34秒前
威武的亦绿完成签到,获得积分10
34秒前
木丁完成签到,获得积分10
35秒前
35秒前
38秒前
量子星尘发布了新的文献求助30
40秒前
孙燕应助成就山河采纳,获得10
41秒前
42秒前
领导范儿应助幸福大白采纳,获得30
43秒前
谓风发布了新的文献求助10
43秒前
44秒前
q1356478314应助天白采纳,获得10
44秒前
Hanni完成签到 ,获得积分10
44秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989406
求助须知:如何正确求助?哪些是违规求助? 3531522
关于积分的说明 11254187
捐赠科研通 3270174
什么是DOI,文献DOI怎么找? 1804901
邀请新用户注册赠送积分活动 882105
科研通“疑难数据库(出版商)”最低求助积分说明 809174